Literature DB >> 21080319

Planning for Rift Valley fever virus: use of geographical information systems to estimate the human health threat of white-tailed deer (Odocoileus virginianus)-related transmission.

Sravan Kakani1, A Desirée LaBeaud, Charles H King.   

Abstract

Rift Valley fever (RVF) virus is a mosquito-borne phlebovirus of the Bunyaviridae family that causes frequent outbreaks of severe animal and human disease in sub-Saharan Africa, Egypt and the Arabian Peninsula. Based on its many known competent vectors, its potential for transmission via aerosolization, and its progressive spread from East Africa to neighbouring regions, RVF is considered a high-priority, emerging health threat for humans, livestock and wildlife in all parts of the world. Introduction of West Nile virus to North America has shown the potential for "exotic" viral pathogens to become embedded in local ecological systems. While RVF is known to infect and amplify within domestic livestock, such as taurine cattle, sheep and goats, if RVF virus is accidentally or intentionally introduced into North America, an important unknown factor will be the role of local wildlife in the maintenance or propagation of virus transmission. We examined the potential impact of RVF transmission via white-tailed deer (Odocoileus virginianus) in a typical north-eastern United States urban-suburban landscape, where livestock are rare but where these potentially susceptible, ungulate wildlife are highly abundant. Model results, based on overlap of mosquito, human and projected deer densities, indicate that a significant proportion (497/1186 km(2), i.e. 42%) of the urban and peri-urban landscape could be affected by RVF transmission during the late summer months. Deer population losses, either by intervention for herd reduction or by RVF-related mortality, would substantially reduce these likely transmission zones to 53.1 km(2), i.e. by 89%.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21080319      PMCID: PMC3140430          DOI: 10.4081/gh.2010.185

Source DB:  PubMed          Journal:  Geospat Health        ISSN: 1827-1987            Impact factor:   1.212


  33 in total

1.  Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya.

Authors:  K J Linthicum; A Anyamba; C J Tucker; P W Kelley; M F Myers; C J Peters
Journal:  Science       Date:  1999-07-16       Impact factor: 47.728

2.  Rift Valley fever among domestic animals in the recent West African outbreak.

Authors:  T G Ksiazek; A Jouan; J M Meegan; B Le Guenno; M L Wilson; C J Peters; J P Digoutte; M Guillaud; N O Merzoug; E M Touray
Journal:  Res Virol       Date:  1989 Jan-Feb

3.  Severe Rift Valley fever may present with a characteristic clinical syndrome.

Authors:  Summerpal S Kahlon; Clarence J Peters; James Leduc; Eric M Muchiri; Samuel Muiruri; M Kariuki Njenga; Robert F Breiman; A Clinton White; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

4.  An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98.

Authors:  Christopher W Woods; Adam M Karpati; Thomas Grein; Noel McCarthy; Peter Gaturuku; Eric Muchiri; Lee Dunster; Alden Henderson; Ali S Khan; Robert Swanepoel; Isabelle Bonmarin; Louise Martin; Philip Mann; Bonnie L Smoak; Michael Ryan; Thomas G Ksiazek; Ray R Arthur; Andre Ndikuyeze; Naphtali N Agata; Clarence J Peters
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

5.  Identification of bloodmeals in Anopheles quadrimaculatus and Anopheles punctipennis from eastern equine encephalitis virus foci in northeastern U.S.A.

Authors:  G Molaei; A Farajollahi; P M Armstrong; J Oliver; J J Howard; T G Andreadis
Journal:  Med Vet Entomol       Date:  2009-12       Impact factor: 2.739

Review 6.  Present and future arboviral threats.

Authors:  Scott C Weaver; William K Reisen
Journal:  Antiviral Res       Date:  2009-10-24       Impact factor: 5.970

7.  Detection of a novel reassortant epizootic hemorrhagic disease virus (EHDV) in the USA containing RNA segments derived from both exotic (EHDV-6) and endemic (EHDV-2) serotypes.

Authors:  A B Allison; V H Goekjian; A C Potgieter; W C Wilson; D J Johnson; P P C Mertens; D E Stallknecht
Journal:  J Gen Virol       Date:  2009-10-14       Impact factor: 3.891

Review 8.  Strategies for reducing the risk of Lyme borreliosis in North America.

Authors:  Joseph Piesman
Journal:  Int J Med Microbiol       Date:  2006-03-09       Impact factor: 3.473

9.  Habitat factors influencing distributions of Anaplasma phagocytophilum and Ehrlichia chaffeensis in the Mississippi Alluvial Valley.

Authors:  J S Manangan; S H Schweitzer; N Nibbelink; M J Yabsley; S E J Gibbs; M C Wimberly
Journal:  Vector Borne Zoonotic Dis       Date:  2007       Impact factor: 2.133

10.  West Nile virus epidemic, northeast Ohio, 2002.

Authors:  Anna M Mandalakas; Christopher Kippes; Joseph Sedransk; Jeffrey R Kile; Asha Garg; John McLeod; Richard L Berry; Anthony A Marfin
Journal:  Emerg Infect Dis       Date:  2005-11       Impact factor: 6.883

View more
  9 in total

1.  Comparison of Rift Valley fever virus replication in North American livestock and wildlife cell lines.

Authors:  Natasha N Gaudreault; Sabarish V Indran; P K Bryant; Juergen A Richt; William C Wilson
Journal:  Front Microbiol       Date:  2015-06-30       Impact factor: 5.640

2.  Natural History of Plasmodium odocoilei Malaria Infection in Farmed White-Tailed Deer.

Authors:  Ann M Guggisberg; Katherine A Sayler; Samantha M Wisely; Audrey R Odom John
Journal:  mSphere       Date:  2018-04-18       Impact factor: 4.389

3.  Combination Kinase Inhibitor Treatment Suppresses Rift Valley Fever Virus Replication.

Authors:  Todd M Bell; Virginia Espina; Lindsay Lundberg; Chelsea Pinkham; Ashwini Brahms; Brian D Carey; Shih-Chao Lin; Bibha Dahal; Caitlin Woodson; Cynthia de la Fuente; Lance A Liotta; Charles L Bailey; Kylene Kehn-Hall
Journal:  Viruses       Date:  2018-04-13       Impact factor: 5.048

4.  Susceptibility of White-Tailed Deer to Rift Valley Fever Virus.

Authors:  William C Wilson; In Joong Kim; Jessie D Trujillo; Sun Young Sunwoo; Leela E Noronha; Kinga Urbaniak; D Scott McVey; Barbara S Drolet; Igor Morozov; Bonto Faburay; Erin E Schirtzinger; Tammy Koopman; Sabarish V Indran; Velmurugan Balaraman; Juergen A Richt
Journal:  Emerg Infect Dis       Date:  2018-09       Impact factor: 6.883

Review 5.  Livestock Challenge Models of Rift Valley Fever for Agricultural Vaccine Testing.

Authors:  Andrea Louise Kroeker; Shawn Babiuk; Bradley S Pickering; Juergen A Richt; William C Wilson
Journal:  Front Vet Sci       Date:  2020-05-27

Review 6.  Rift Valley Fever Virus, Japanese Encephalitis Virus, and African Swine Fever Virus: Three Transboundary, Vector-Borne, Veterinary Biothreats With Diverse Surveillance, and Response Capacity Needs.

Authors:  Rebekah C Kading; Edward O Abworo; Gabriel L Hamer
Journal:  Front Vet Sci       Date:  2019-12-13

7.  Paving the way for human vaccination against Rift Valley fever virus: A systematic literature review of RVFV epidemiology from 1999 to 2021.

Authors:  Keli N Gerken; A Desirée LaBeaud; Henshaw Mandi; Maïna L'Azou Jackson; J Gabrielle Breugelmans; Charles H King
Journal:  PLoS Negl Trop Dis       Date:  2022-01-24

8.  Data-driven modeling to assess receptivity for Rift Valley Fever virus.

Authors:  Christopher M Barker; Tianchan Niu; William K Reisen; David M Hartley
Journal:  PLoS Negl Trop Dis       Date:  2013-11-14

9.  Predicting the mosquito species and vertebrate species involved in the theoretical transmission of Rift Valley fever virus in the United States.

Authors:  Andrew J Golnar; Michael J Turell; A Desiree LaBeaud; Rebekah C Kading; Gabriel L Hamer
Journal:  PLoS Negl Trop Dis       Date:  2014-09-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.